The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Veterinary Renal Disease Global Market Report 2024, the veterinary renal disease market is expected to show significant growth in the forecast period.

The veterinary renal disease market has experienced substantial growth recently and is poised for further expansion. This blog explores the key drivers, emerging trends, and future outlook for the market, highlighting the impact of increasing pet ownership, advancements in veterinary medicine, and strategic corporate developments.

Market Growth Overview

• Current Market Size: The veterinary renal disease market was valued at $14.55 billion in 2023.
• Short-Term Growth: It is projected to grow to $15.33 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.8%.
• Long-Term Projections: By 2028, the market is expected to reach $20.36 billion, with a CAGR of 7%.

Key Drivers:

• Disease Awareness Initiatives: Increased efforts to educate pet owners about renal diseases.
• Natural and Organic Pet Food: A shift towards healthier pet diets.
• Rising Pet Ownership: Higher global rates of pet ownership.
• Regulatory Changes: New regulations in veterinary pharmaceuticals.
• Pet Health Awareness: Growing focus on overall pet health and nutrition.

View More On The Veterinary Renal Disease Market Report 2024 – https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Increasing Pet Ownership Fuels Market Expansion

• Impact of Pet Ownership: The surge in pet ownership significantly drives market growth, as more pets mean a higher incidence of renal diseases.
• Disease Impact: Veterinary renal diseases, such as chronic kidney disease (CKD), affect kidney function in pets, causing symptoms like increased thirst and weight loss.
• Pet Population: As reported by Cooper Pet Care, Europe saw an increase in pet population to approximately 145 million in 2022, including 66 million dogs and 79 million cats.

Growth Factors:

• Longer Pet Lifespans: Pets are living longer, increasing the incidence of chronic diseases.
• Environmental and Dietary Factors: Exposure to toxins and dietary factors contribute to renal diseases.
• Genetic Predispositions: Some pets are more prone to kidney issues due to genetics.

Advancements in Diagnosis and Treatment

• New Diagnostic Tools: IDEXX Laboratories launched the IDEXX Cystatin B Test in June 2023. This test detects kidney injury before noticeable symptoms arise, allowing for early intervention and better outcomes.
• Technological Integration: The test will be included in panels used during millions of patient visits annually, enhancing diagnostic accuracy.

Innovation Focus:

• Early Detection: New tests aim to identify subtle changes in kidney function or structure.
• Treatment Improvements: Enhanced treatment options for managing symptoms and slowing disease progression.

Strategic Corporate Developments

• Dechra Pharmaceuticals Acquisition: In July 2022, Dechra Pharmaceuticals acquired Piedmont Animal Health for $210 million. This acquisition strengthens Dechra’s product development capabilities and expands its portfolio in veterinary renal disease treatments.

Strategic Moves:

• Enhanced Product Pipeline: The acquisition accelerates innovation in veterinary renal disease treatments.
• Market Positioning: Strengthens Dechra’s presence in the veterinary market.

Market Segmentation and Regional Insights

• By Type: Diagnosis, Treatment
• By Animal Type: Canine, Feline, Bovine, Equine, Other
• By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other
• By Route of Administration: Injectable, Oral
• By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other

Regional Insights:

• North America: The largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

The veterinary renal disease market is set for robust growth, driven by increasing pet ownership, advancements in diagnostic and treatment technologies, and strategic corporate expansions. As the industry evolves, emerging trends and innovations will continue to shape the future of veterinary care.

Request A Sample Of The Global Veterinary Renal Disease Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15957&type=smp